Attention Deficit/ Hyperactivity Disorder (ADHD)
Join a study exploring potential treatments with a new class of investigational medication.
A clinical trial is enrolling adults aged 13–17 with a Bipolar Depression.
To pre-qualify for this study, participants must:
Be between 13 to 17 years old.
Have a primary diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD).
Be fluent in English and able to communicate effectively.
Be willing and able to provide assent, along with parental/guardian consent.
Be either naive to stimulant and/or non-stimulant ADHD medications or have been off them for at least 4 weeks.